Literature DB >> 26304694

Smoking to Regulate Negative Affect: Disentangling the Relationship Between Posttraumatic Stress and Emotional Disorder Symptoms, Nicotine Dependence, and Cessation-Related Problems.

Brittain L Mahaffey1, Adam Gonzalez2, Samantha G Farris3, Michael J Zvolensky4, Evelyn J Bromet2, Benjamin J Luft5, Roman Kotov2.   

Abstract

INTRODUCTION: Posttraumatic stress disorder (PTSD) is associated with various aspects of cigarette smoking, including higher levels of nicotine dependence and cessation difficulties. Affect-regulatory smoking motives are thought to, in part, underlie the association between emotional disorders such as PTSD and smoking maintenance, although few studies have empirically tested this possibility.
METHODS: Data were analyzed from 135 treatment-seeking smokers who were directly exposed to the World Trade Center disaster on September 11, 2001. We modeled the direct effect of 9/11 PTSD symptom severity on nicotine dependence, perceived barriers to smoking cessation, and severity of problematic symptoms experienced during prior cessation attempts. We also examined the indirect effect of PTSD on these outcomes via negative affect reduction smoking motives. Parallel models were constructed for additional emotional disorder symptoms, including panic and depressive symptoms.
RESULTS: PTSD symptom severity was associated with nicotine dependence and perceived barriers to cessation, but not problems during prior quit attempts indirectly via negative affect reduction smoking motives. Panic and depressive symptoms both had significant indirect effects, via negative affect reduction smoking motives, on all three criterion variables.
CONCLUSIONS: Affect-regulatory smoking motives appear to underlie associations between the symptoms of emotional disorders such as PTSD, panic, and depression in terms of smoking dependence and certain cessation-related criterion variables. IMPLICATIONS: Overall, this investigation suggests negative affect reduction smoking motives help to explain the relationship of PTSD, depression, and panic symptoms to nicotine dependence, severity of problems experienced during prior quit attempts and perceived barriers to cessation. These results highlight the importance of assessing motivations for smoking in the context of cessation treatment, especially among those with emotional disorder symptoms. Future interventions might seek to utilize motivational interviewing and cognitive restructuring techniques to address coping-oriented motives for smoking, in addition to skills for managing negative affect, as a means of improving quit outcomes.
© The Author 2015. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2015        PMID: 26304694     DOI: 10.1093/ntr/ntv175

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  11 in total

1.  Psychometric evaluation of the Barriers to Cessation Scale.

Authors:  Lorra Garey; Charles Jardin; Brooke Y Kauffman; Carla Sharp; Clayton Neighbors; Norman B Schmidt; Michael J Zvolensky
Journal:  Psychol Assess       Date:  2016-08-15

2.  A prospective investigation of the synergistic effect of change in anxiety sensitivity and dysphoria on tobacco withdrawal.

Authors:  Jafar Bakhshaie; Paulina A Kulesz; Lorra Garey; Kirsten J Langdon; Michael S Businelle; Adam M Leventhal; Matthew W Gallagher; Norman B Schmidt; Kara Manning; Renee Goodwin; Michael J Zvolensky
Journal:  J Consult Clin Psychol       Date:  2017-11-27

3.  Relations Between Parental Distress Intolerance, Adolescent Motives for Cigarette Use, and Adolescent Cigarette Smoking Levels.

Authors:  Sarah A Bilsky; Renee M Cloutier; Casey R Guillot; Teah M Bynion; Sarah F Lewis
Journal:  Subst Use Misuse       Date:  2019-07-12       Impact factor: 2.164

4.  The association between cognitive coping strategies and treatment outcomes in smokers with PTSD.

Authors:  Anu Asnaani; Antonia N Kaczkurkin; Hayley E Fitzgerald; Alissa Jerud; Edna B Foa
Journal:  Psychol Trauma       Date:  2019-05-23

5.  The Relationship Between Neighborhood Disorder and Barriers to Cessation in a Sample of Impoverished Inner-City Smokers in Baltimore, Maryland, United States.

Authors:  Carl A Latkin; Ryan D Kennedy; Melissa A Davey-Rothwell; Tuo-Yen Tseng; Lauren Czaplicki; Anirudh Baddela; Catie Edwards; Geetanjali Chander; Meghan B Moran; Amy R Knowlton
Journal:  Nicotine Tob Res       Date:  2018-11-15       Impact factor: 4.244

6.  Examining the relationship between negative affect and posttraumatic stress disorder symptoms among smokers using ecological momentary assessment.

Authors:  Meredith C Erwin; Paul A Dennis; Lara N Coughlin; Patrick S Calhoun; Jean C Beckham
Journal:  J Affect Disord       Date:  2019-04-09       Impact factor: 4.839

7.  Posttraumatic stress disorder and tobacco use: A systematic review and meta-analysis.

Authors:  Irene Pericot-Valverde; Rebecca J Elliott; Mollie E Miller; Jennifer W Tidey; Diann E Gaalema
Journal:  Addict Behav       Date:  2018-05-03       Impact factor: 3.913

8.  Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: A randomized controlled trial.

Authors:  Edna B Foa; Anu Asnaani; David Rosenfield; Laurie J Zandberg; Peter Gariti; Patricia Imms
Journal:  J Consult Clin Psychol       Date:  2017-06-01

9.  Associations between child maltreatment, cigarette smoking, and nicotine dependence in young adults with a history of regular smoking.

Authors:  Alison L Cammack; Regine Haardörfer; Shakira F Suglia
Journal:  Ann Epidemiol       Date:  2019-10-21       Impact factor: 3.797

10.  Treatment attrition: Associations with negative affect smoking motives and barriers to quitting among treatment-seeking smokers.

Authors:  Lorra Garey; Brooke Y Kauffman; Clayton Neighbors; Norman B Schmidt; Michael J Zvolensky
Journal:  Addict Behav       Date:  2016-08-01       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.